This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Rafael’s 8K filing here.
About Rafael
Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
See Also
- Five stocks we like better than Rafael
- Buy P&G Now, Before It Sets A New All-Time High
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is an Earnings Surprise?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a buyback in stocks? A comprehensive guide for investors
- GRAIL: Biotech Stock Targeting $100B Cancer Market
